Beverly Davidson

Beverly L. Davidson is an American geneticist. She is the director of the Raymond G. Perelman Center for Cellular and Molecular Therapeutics at Children's Hospital of Philadelphia. In this role, she investigates gene therapy for neurodegenerative diseases, specifically Huntington's.

In 2019, Davidson was elected a member of the National Academy of Medicine for her "being on the forefront of developing innovative therapies and medicines for fatal, inherited brain disorders, which are engineered to either remove toxic proteins or replace missing proteins, and for improving or preventing disease progression." Provided by Wikipedia
Showing 1 - 10 results of 10 for search 'Beverly L. Davidson', query time: 0.07s Refine Results
  1. 1
    Taking a Break From Huntingtin

    Taking a Break From Huntingtin by Beverly L Davidson

    Published 2012
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure

    Gene Silencing Mediated by siRNA-binding Fusion Proteins Is Attenuated by Double-stranded RNA-binding Domain Structure by James C Geoghegan, Brian L Gilmore, Beverly L Davidson

    Published 2012
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Cas9 editing of ATXN1 in a spinocerebellar ataxia type 1 mice and human iPSC-derived neurons

    Cas9 editing of ATXN1 in a spinocerebellar ataxia type 1 mice and human iPSC-derived neurons by Kelly J. Fagan, Guillem Chillon, Ellie M. Carrell, Elisa A. Waxman, Beverly L. Davidson

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    In vivo SELEX for Identification of Brain-penetrating Aptamers

    In vivo SELEX for Identification of Brain-penetrating Aptamers by Congsheng Cheng, Yong Hong Chen, Kim A Lennox, Mark A Behlke, Beverly L Davidson

    Published 2013
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity

    Temporal restriction of Cas9 expression improves CRISPR-mediated deletion efficacy and fidelity by Jesse A. Weber, Jonathan F. Lang, Ellie M. Carrell, Mohamad-Gabriel Alameh, Beverly L. Davidson

    Published 2024
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo

    Artificial miRNAs Targeting Mutant Huntingtin Show Preferential Silencing In Vitro and In Vivo by Alex Mas Monteys, Matthew J Wilson, Ryan L Boudreau, Ryan M Spengler, Beverly L Davidson

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo

    Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo by James C Geoghegan, Nicholas W Keiser, Anna Okulist, Inês Martins, Matthew S Wilson, Beverly L Davidson

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Platelet Activating Factor Receptor Activation Improves siRNA Uptake and RNAi Responses in Well-differentiated Airway Epithelia

    Platelet Activating Factor Receptor Activation Improves siRNA Uptake and RNAi Responses in Well-differentiated Airway Epithelia by Sateesh Krishnamurthy, Mark A Behlke, Michael A Apicella, Paul B McCray, Jr, Beverly L Davidson

    Published 2014
    Connect to this object online.
    Book
    Save to List
    Saved in:
  9. 9
    Manipulation of Cell Physiology Enables Gene Silencing in Well-differentiated Airway Epithelia

    Manipulation of Cell Physiology Enables Gene Silencing in Well-differentiated Airway Epithelia by Sateesh Krishnamurthy, Mark A Behlke, Shyam Ramachandran, Aliasger K Salem, Paul B McCray Jr, Beverly L Davidson

    Published 2012
    Connect to this object online.
    Book
    Save to List
    Saved in:
  10. 10
    VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF

    VWA3A-derived ependyma promoter drives increased therapeutic protein secretion into the CSF by Ellie M. Carrell, Yong Hong Chen, Paul T. Ranum, Stephanie L. Coffin, Larry N. Singh, Luis Tecedor, Megan S. Keiser, Eloise Hudry, Bradley T. Hyman, Beverly L. Davidson

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: